Interleukin 2 (IL-2) is a key growth factor for the clonal expansion of antigen activated T lymphocytes whose biological activity is mediated by binding to the high affinity IL-2 receptor (IL-2R), comprised of 3 subunits, alpha, beta and gamma. Signal transduction via the IL-2R is dependent upon the cytoplasmic tails of the beta and gamma subunits. The gamma subunit (designated gamma-c) has been recently shown to be a component of the lL-4 receptor (IL-4R) and IL-7 receptor (IL-7R), and it is highly likely a component of the IL-9R and lL-15R. Proper signal transduction from gamma-c is critical for normal lymphocyte development as mutations in the human gamma-c gene has been causally associated with X- linked severe combined immunodeficiency disease (SCID). A key issue, therefore, for understanding how not only the IL-2R but also cytokine receptors in general regulate the immune system is to establish the function of gamma-c. During the last grant period, cDNA probes and unique monoclonal antibodies (mAbs) to the IL-2Rbeta and gamma-c were generated to facilitate study of the mouse IL-2R. An in vivo system have been developed that appears to be a mouse model of X-linked SCID. By adoptive transfer of bone marrow cells and subsequent treatment of the recipient with mAbs to gamma-c, preliminary data demonstrate that gamma-c bearing cells are required for mouse T and B cell development from progenitor cells in adult bone marrow. The major objectives of this proposal are to establish the contribution of the gamma-c in T lymphocyte development and to define the physiological relevant role of cytoplasmic domains of IL-2Rbeta and gamma-c in T cell growth and differentiation into effector cells.
The specific aims are: 1) To establish the contribution of gamma-c on T and B lymphocyte development from embryonic and adult bone marrow progenitor cells; 2) to delineate whether gamma-c signalling promotes intrathymic T cell development: and 3) to determine the functional activity of lL-2Rbeta and gamma-c signal transducing modules in normal T lymphocytes. The first 2 aims will by pursued by detailed characterization of the anti-gamma-c mouse model of SCID and by production and characterization of dominant negative transgenic mice in which gamma-c signalling is inhibited in distinct cellular compartments.
For aim 3 chimeric IL-2R will be expressed in transgenic mice that are akin to producing a """"""""knockout"""""""" mouse in which discrete functional cytoplasmic domains of IL-2Rbeta or gamma-c have been mutated to test the contribution of that domain on T cell growth and differentiation into effector cells by normal T lymphocytes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045957-11
Application #
2390696
Study Section
Special Emphasis Panel (ZRG5-EI (03))
Project Start
1987-06-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33146
Cheng, Guoyan; Yu, Aixin; Dee, Michael J et al. (2013) IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J Immunol 190:1567-75
Cheng, Guoyan; Yuan, Xiaomei; Tsai, Matthew S et al. (2012) IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J Immunol 189:1780-91
Yuan, Xiaomei; Malek, Thomas R (2012) Cellular and molecular determinants for the development of natural and induced regulatory T cells. Hum Immunol 73:773-82
Cheng, Guoyan; Yu, Aixin; Malek, Thomas R (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241:63-76
Malek, Thomas R; Castro, Iris (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33:153-65
Yu, Aixin; Zhu, Linjian; Altman, Norman H et al. (2009) A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30:204-17
Bayer, Allison L; Lee, Joon Youb; de la Barrera, Anabel et al. (2008) A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 181:225-34
Yu, Aixin; Malek, Thomas R (2006) Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells. J Immunol 177:5115-21
Adeegbe, Dennis; Bayer, Allison L; Levy, Robert B et al. (2006) Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 176:7149-53
Jin, Haoli; Carrio, Roberto; Yu, Aixin et al. (2004) Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 173:657-65

Showing the most recent 10 out of 20 publications